OCRA News
OCRA-Funded Study Reveals Role of L1CAM in Development and Spread of HGSOC
A recent study, funded in part by OCRA, has shed new light on how the most common subtype of ovarian cancer develops and metastasizes…
The world’s leader in the fight against ovarian cancer
Why OCRA?
Only one organization has both a laser focus and a panoramic view. Learn more about our impact.
Everything you need to know about symptoms, risk factors, diagnosis, stages, subtypes and more
News & Updates
OCRA News
OCRA-Funded Research Sheds Light On Ovarian Cancer Resistance to Chemotherapy
As immunotherapies have seen rising success in treating several other cancers, researchers are hard at work uncovering why immunotherapy for ovarian cancer has, so far, proven ineffective. …
Community
Melica Brodeur, MD, MSc | Meet a Scientist
Dr. Melica Brodeur Dr. Melica Brodeur, of Memorial Sloan Kettering Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project…
